HER2 Support Group Forums - Halozyme Announces Roche Doses First Patient In Phase 3 Clinical Trial With Subcutane

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - Halozyme Announces Roche Doses First Patient In Phase 3 Clinical Trial With Subcutane (https://her2support.org/vbulletin/showthread.php?t=41539)

News	10-22-2009 08:10 PM

Halozyme Announces Roche Doses First Patient In Phase 3 Clinical Trial With Subcutane

Halozyme Therapeutics, Inc. (Nasdaq:HALO) and Roche announced dosing of the first patient in a Phase 3 registration trial using Enhanze? technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation with Roche's anticancer biologic, Herceptin (trastuzumab).

More...

All times are GMT -7. The time now is 09:38 PM.